February 9, 2024JAMA Neurology

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

View Full Paper

Ask AI

Bookmark

Authors

KSKevin N. ShethYale New Haven Hospital NSNicole SolomonHeart Failure & Transplant BABrooke AlhantiHeart Failure / Cardiomyopathy

Discussion

Member takes

Implication

Clinical analysis reports uncertain effects of door-to-treatment intervals in anticoagulation-associated intracerebral hemorrhage, highlighting undefined benefits of rapid reversal.

Key Points

Anticoagulation reversal strategies currently show an uncertain time-dependent treatment effect across clinical practice in anticoagulation-associated intracerebral hemorrhage.
Mortality rates remain exceptionally elevated for anticoagulation-associated intracerebral hemorrhage, which represents the deadliest recognized subtype of acute stroke.
Door-to-treatment time evaluation highlights pressing therapeutic uncertainties, calling for structured investigations into rapid anticoagulation reversal in emergency care.

Cite This Study

Sheth et al. (2024) studied this question.

synapsesocial.com/papers/68e79c4cb6db64358770b784 https://doi.org/10.1001/jamaneurol.2024.0221

View Full Paper

Ask AI

Bookmark

Implication

Clinical analysis reports uncertain effects of door-to-treatment intervals in anticoagulation-associated intracerebral hemorrhage, highlighting undefined benefits of rapid reversal.

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

Discussion

Member takes

Implication

Key Points

Cite This Study

Time to Anticoagulation Reversal and Outcomes After Intracerebral Hemorrhage

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider